Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro M Rodrigues

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Science Translational Medicine|March 15, 2023
Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunityInês Alves, Beatriz Santos-Pereira, Noelia de la Cruz, et al.
Hepatology (Baltimore, Md.)|February 10, 2026
Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytesEnara Markaide, Laura Izquierdo-Sanchez, Irene Olaizola, et al.
Gut|December 28, 2020
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver diseaseMarta B Afonso, Pedro M Rodrigues, Miguel Mateus-Pinheiro, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humansFrancisco J Caballero-Camino, Pedro M Rodrigues, Fredrik Wångsell, et al.
Hepatology (Baltimore, Md.)|March 8, 2020
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver DiseaseFrancisco J Caballero-Camino, Ivan Rivilla, Elisa Herraez, et al.
Clinical Science (London, England : 1979)|June 6, 2025
Primary bile acid shapes peripheral immunity in inflammatory bowel disease-associated primary sclerosing cholangitisAndré A Santos, David Pires, Vanda Marques, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2023
miR-21-5p promotes NASH-related hepatocarcinogenesisPedro M Rodrigues, Marta B Afonso, André L Simão, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 8, 2020
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targetsAlvaro Santos-Laso, Laura Izquierdo-Sanchez, Pedro M Rodrigues, et al.
Lancet Regional Health. Americas|December 10, 2024
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomesLeonardo G da Fonseca, Laura Izquierdo-Sanchez, Pedro H Hashizume, et al.
Clinical Reviews in Allergy & Immunology|September 3, 2020
Are Physicochemical Properties Shaping the Allergenic Potency of Plant Allergens?Joana Costa, Simona Lucia Bavaro, Sara Benedé, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Science Translational Medicine|March 15, 2023
Host-derived mannose glycans trigger a pathogenic γδ T cell/IL-17a axis in autoimmunityInês Alves, Beatriz Santos-Pereira, Noelia de la Cruz, et al.
Hepatology (Baltimore, Md.)|February 10, 2026
Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytesEnara Markaide, Laura Izquierdo-Sanchez, Irene Olaizola, et al.
Gut|December 28, 2020
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver diseaseMarta B Afonso, Pedro M Rodrigues, Miguel Mateus-Pinheiro, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humansFrancisco J Caballero-Camino, Pedro M Rodrigues, Fredrik Wångsell, et al.
Hepatology (Baltimore, Md.)|March 8, 2020
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver DiseaseFrancisco J Caballero-Camino, Ivan Rivilla, Elisa Herraez, et al.
Clinical Science (London, England : 1979)|June 6, 2025
Primary bile acid shapes peripheral immunity in inflammatory bowel disease-associated primary sclerosing cholangitisAndré A Santos, David Pires, Vanda Marques, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 3, 2023
miR-21-5p promotes NASH-related hepatocarcinogenesisPedro M Rodrigues, Marta B Afonso, André L Simão, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 8, 2020
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targetsAlvaro Santos-Laso, Laura Izquierdo-Sanchez, Pedro M Rodrigues, et al.
Lancet Regional Health. Americas|December 10, 2024
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomesLeonardo G da Fonseca, Laura Izquierdo-Sanchez, Pedro H Hashizume, et al.
Clinical Reviews in Allergy & Immunology|September 3, 2020
Are Physicochemical Properties Shaping the Allergenic Potency of Plant Allergens?Joana Costa, Simona Lucia Bavaro, Sara Benedé, et al.
Pageof 12